trial · primary record
Intensity-Modulated Radiation Therapy
Stage II Prostate Adenocarcinoma AJCC v7
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 698 |
| Primary completion | 2027-12-01 |
| Primary endpoint | Number of Participants With a Decline of ≥4 Points in the EPIC-26 Bowel Domain (Minimal Clinically Important Difference) at Two Years |
| Registry ID | NCT03367702 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:31:45.390Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03367702
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.